Request for Covid-19 Impact Assessment of this Report
Geographically, the global GI tract (Upper and Lower) market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total GI tract (Upper and Lower) market in North America.
Significant participants active in the global GI tract (Upper and Lower) market include: AstraZeneca, Bayer AG, GlaxoSmithKline PLC, Pfizer Inc., Abbott Laboratories, Allergan PLC, AbbVie Inc., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Astellas Pharma Inc....
Global GI tract (Upper and Lower) Market Segmentation:
GI tract (Upper and Lower) market, by GI tract (Upper and Lower) type:
Antacids
Laxatives
Antidiarrheal agents
Antiemetics
Antiulcer agents
Other Drug Types
…
GI tract (Upper and Lower) market, by Application:
Inflammatory Ulcerative Colitis
Cyclic vomiting syndrome (CVS)
Dyspepsia
Dysphagia
Gastroesophageal reflux disease (GERD)
Irritable Bowel Syndrome
Crohn's Disease
Celiac Disease
Gastroenteritis
Other Applications
…
GI tract (Upper and Lower) Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of GI tract (Upper and Lower) by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global GI tract (Upper and Lower) Market-Segmentation
4.1 By Type
4.1.1 Antacids
4.1.2 Laxatives
4.1.3 Antidiarrheal agents
4.1.4 Antiemetics
4.1.5 Antiulcer agents
4.1.6 Other Drug Types
4.2 By End-User/Application Industry
4.2.1 Inflammatory Ulcerative Colitis
4.2.2 Cyclic vomiting syndrome (CVS)
4.2.3 Dyspepsia
4.2.4 Dysphagia
4.2.5 Gastroesophageal reflux disease (GERD)
4.2.6 Irritable Bowel Syndrome
4.2.7 Crohn's Disease
4.2.8 Celiac Disease
4.2.9 Gastroenteritis
4.2.10 Other Applications
4.3 By Geography
4.3.1 North America GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America GI tract (Upper and Lower) Production from 2014-2020
4.3.1.2 North America GI tract (Upper and Lower) Consumption from 2014-2020
4.3.1.3 North America GI tract (Upper and Lower) Import and Export from 2014-2020
4.3.1.4 North America GI tract (Upper and Lower) Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America GI tract (Upper and Lower) Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America GI tract (Upper and Lower) Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe GI tract (Upper and Lower) Production from 2014-2020
4.3.2.2 Europe GI tract (Upper and Lower) Consumption from 2014-2020
4.3.2.3 Europe GI tract (Upper and Lower) Import and Export from 2014-2020
4.3.2.4 Europe GI tract (Upper and Lower) Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe GI tract (Upper and Lower) Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific GI tract (Upper and Lower) Production from 2014-2020
4.3.3.2 Asia-Pacific GI tract (Upper and Lower) Consumption from 2014-2020
4.3.3.3 Asia-Pacific GI tract (Upper and Lower) Import and Export from 2014-2020
4.3.3.4 Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America GI tract (Upper and Lower) Production from 2014-2020
4.3.4.2 Latin America GI tract (Upper and Lower) Consumption from 2014-2020
4.3.4.3 Latin America GI tract (Upper and Lower) Import and Export from 2014-2020
4.3.4.4 Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa GI tract (Upper and Lower) Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa GI tract (Upper and Lower) Production from 2014-2020
4.3.5.2 Middle East & Africa GI tract (Upper and Lower) Consumption from 2014-2020
4.3.5.3 Middle East & Africa GI tract (Upper and Lower) Import and Export from 2014-2020
4.3.5.4 Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Bayer AG
5.2.1 Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Bayer AG Sales, Growth Rate and Global Market Share from 2014-2020
5.3 GlaxoSmithKline PLC
5.3.1 GlaxoSmithKline PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 GlaxoSmithKline PLC Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Pfizer Inc.
5.4.1 Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Allergan PLC
5.6.1 Allergan PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Allergan PLC Sales, Growth Rate and Global Market Share from 2014-2020
5.7 AbbVie Inc.
5.7.1 AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 AbbVie Inc. Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Janssen Pharmaceuticals Inc. (Johnson & Johnson)
5.8.1 Janssen Pharmaceuticals Inc. (Johnson & Johnson) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Janssen Pharmaceuticals Inc. (Johnson & Johnson) Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Astellas Pharma Inc.
5.9.1 Astellas Pharma Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Astellas Pharma Inc. Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global GI tract (Upper and Lower) Market from 2021-2026
7.1 Future Forecast of Global GI tract (Upper and Lower) Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global GI tract (Upper and Lower) Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global GI tract (Upper and Lower) Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global GI tract (Upper and Lower) Market Value ($) and Growth Rate of GI tract (Upper and Lower) from 2014-2026
Global GI tract (Upper and Lower) Production and Growth Rate Segment by Product Types from 2014-2026F
Global GI tract (Upper and Lower) Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global GI tract (Upper and Lower) Production and Growth Rate Segment by Product Types from 2014-2020
Table Global GI tract (Upper and Lower) Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Antacids of GI tract (Upper and Lower)
Figure Laxatives of GI tract (Upper and Lower)
Figure Antidiarrheal agents of GI tract (Upper and Lower)
Figure Antiemetics of GI tract (Upper and Lower)
Figure Antiulcer agents of GI tract (Upper and Lower)
Figure Other Drug Types of GI tract (Upper and Lower)
Table Global GI tract (Upper and Lower) Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global GI tract (Upper and Lower) Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Inflammatory Ulcerative Colitis of GI tract (Upper and Lower)
Figure Cyclic vomiting syndrome (CVS) of GI tract (Upper and Lower)
Figure Dyspepsia of GI tract (Upper and Lower)
Figure Dysphagia of GI tract (Upper and Lower)
Figure Gastroesophageal reflux disease (GERD) of GI tract (Upper and Lower)
Figure Irritable Bowel Syndrome of GI tract (Upper and Lower)
Figure Crohn's Disease of GI tract (Upper and Lower)
Figure Celiac Disease of GI tract (Upper and Lower)
Figure Gastroenteritis of GI tract (Upper and Lower)
Figure Other Applications of GI tract (Upper and Lower)
Table Global GI tract (Upper and Lower) Production Value ($) by Regions
Table Global GI tract (Upper and Lower) Production Value Share by Regions
Table Global GI tract (Upper and Lower) Production by Regions
Table Global GI tract (Upper and Lower) Production Share by Regions
Table Global GI tract (Upper and Lower) Consumption by Regions
Table Global GI tract (Upper and Lower) Consumption Share by Regions
Figure North America GI tract (Upper and Lower) Production and Growth Rate from 2014-2020
Figure North America GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020
Table North America GI tract (Upper and Lower) Import and Export from 2014-2020
Table North America GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
Table North America GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
Table North America GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
Figure Europe GI tract (Upper and Lower) Production and Growth Rate from 2014-2020
Figure Europe GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020
Table Europe GI tract (Upper and Lower) Import and Export from 2014-2020
Table Europe GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
Table Europe GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
Table Europe GI tract (Upper and Lower) Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific GI tract (Upper and Lower) Production and Growth Rate from 2014-2020
Figure Asia-Pacific GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020
Table Asia-Pacific GI tract (Upper and Lower) Import and Export from 2014-2020
Table Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
Figure Latin America GI tract (Upper and Lower) Production and Growth Rate from 2014-2020
Figure Latin America GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020
Table Latin America GI tract (Upper and Lower) Import and Export from 2014-2020
Table Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
Table Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
Table Latin America GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa GI tract (Upper and Lower) Production and Growth Rate from 2014-2020
Figure Middle East & Africa GI tract (Upper and Lower) Consumption and Growth Rate from 2014-2020
Table Middle East & Africa GI tract (Upper and Lower) Import and Export from 2014-2020
Table Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa GI tract (Upper and Lower) Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa GI tract (Upper and Lower) Participants Value ($) and Market Share (%) in 2019
Table AstraZeneca Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure AstraZeneca Sales and Growth Rate from 2014-2020
Figure AstraZeneca Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Bayer AG Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Bayer AG Sales and Growth Rate from 2014-2020
Figure Bayer AG Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table GlaxoSmithKline PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure GlaxoSmithKline PLC Sales and Growth Rate from 2014-2020
Figure GlaxoSmithKline PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Pfizer Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Pfizer Inc. Sales and Growth Rate from 2014-2020
Figure Pfizer Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Abbott Laboratories Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Abbott Laboratories Sales and Growth Rate from 2014-2020
Figure Abbott Laboratories Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Allergan PLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Allergan PLC Sales and Growth Rate from 2014-2020
Figure Allergan PLC Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure AbbVie Inc. Sales and Growth Rate from 2014-2020
Figure AbbVie Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Janssen Pharmaceuticals Inc. (Johnson & Johnson) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Janssen Pharmaceuticals Inc. (Johnson & Johnson) Sales and Growth Rate from 2014-2020
Figure Janssen Pharmaceuticals Inc. (Johnson & Johnson) Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Astellas Pharma Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Astellas Pharma Inc. Sales and Growth Rate from 2014-2020
Figure Astellas Pharma Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global GI tract (Upper and Lower) Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global GI tract (Upper and Lower) Production and Growth Rate Forecast by Regions (2021-2026)
Table Global GI tract (Upper and Lower) Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global GI tract (Upper and Lower) Production and Growth Rate Forecast by Types (2021-2026)
Table Global GI tract (Upper and Lower) Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...